CIK: 0001232621 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 14, 2014
Total Value ($000): $142,994 (53.7% shares, 46.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PDL BIOPHARMA INC | 25,974,000 | $38,616 | 27.0% | $1.41 | — | NOTE 2.875% 2/15/15 | 69329YAE4 |
| — | SALIX PHARMACEUTICALS INC | 300,000 | $26,982 | 18.9% | $66.15 | — | COM | 795435106 |
| — | OPKO HEALTH INC | 14,000,000 | $17,050 | 11.9% | $1.04 | — | NOTE 3.0% 2/1/33 | 68375NAA1 |
| — | MIRATI THERAPEUTICS INC | 938,543 | $15,608 | 10.9% | $15.15 | — | COM | 60468T105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $12,825 | 9.0% | $62.32 | +9.0% | COM | 09061G101 |
| — | INTERMUNE INC | 12,000,000 | $10,575 | 7.4% | $0.83 | — | NOTE 2.50% 9/15/18 | 45884XAE3 |
| — | ONCOGENEX PHARMACEUTICALS INC | 1,033,100 | $8,616 | 6.0% | $9.66 | — | COM | 68230A106 |
| — | MANNKIND CORP | 1,070,419 | $5,566 | 3.9% | $5.20 | — | COM | 56400P201 |
| — | ENDOCYTE INC | 465,763 | $4,974 | 3.5% | $13.13 | — | COM | 29269A102 |
| — | SOPHIRIS BIO INC | 500,000 | $1,850 | 1.3% | $4.68 | — | COM | 83578Q209 |
| — | DENDREON CORP | 79,600 | $238 | 0.2% | $4.12 | — | COM | 24823Q107 |
| OPK | OPKO HEALTH INC | 11,195 | $94 | 0.1% | $10.11 | 0.0% | COM | 68375N103 |
| — | AMBIT BIOSCIENCES CORP | 46 | $0 | 0.0% | — | — | COM | 02318X100 |